TY - JOUR
T1 - Substrate mapping for scar-related ventricular tachycardia in patients with resynchronization therapy—the importance of the pacing mode
AU - Baldinger, Samuel H.
AU - Kumar, Saurabh
AU - Fujii, Akira
AU - Haeberlin, Andreas
AU - Romero, Jorge
AU - Epstein, Laurence M.
AU - Michaud, Gregory F.
AU - Tedrow, Usha B.
AU - John, Roy
AU - Stevenson, William G.
N1 - Funding Information:
Dr. Epstein receives consulting fees from Boston Scientific, Medtronic, and Spectranetics. Dr. John receives consulting fees from St. Jude Medical. Dr. Michaud and Dr. Tedrow receive consulting fees from St. Jude Medical and research funding from Boston Scientific and Biosense Webster. Dr. Stevenson is coholder of a patent for needle ablation that is consigned to Brigham and Women’s Hospital. Dr. Stevenson’s spouse receives research support from St. Jude Medical, Inc.
Funding Information:
Author contributions Samuel H. Baldinger: concept/design, data analysis/interpretation, drafting of manuscript Saurabh Kumar: concept/design, data collection, critical revision Akira Fujii: data collection, critical revision Andreas Haeberlin: statistics, critical revision Jorge Romero: critical revision Laurence M. Epstein: critical revision Gregory F. Michaud: critical revision Roy John: critical revision Usha B. Tedrow: critical revision William G. Stevenson: concept/design, data interpretation, critical revision Funding sources Dr. Baldinger received educational grants from the University Hospital of Bern, Switzerland, and the Swiss foundation for pacemakers and electrophysiology.
Publisher Copyright:
© 2019, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2019/6/15
Y1 - 2019/6/15
N2 - Purpose: Targets for substrate-based catheter ablation of scar-related ventricular tachycardia (VT) include sites with fractionated and late potentials (LPs). We hypothesized that in patients with cardiac resynchronization therapy (CRT), the pacing mode may influence the timing of abnormal electrograms (EGMs) relative to the surface QRS complex. Methods: We assessed bipolar EGM characteristics in left ventricular low bipolar voltage areas (< 1.5 mV) from 10 patients with coronary disease and a CRT device undergoing catheter ablation for VT. EGMs at 81 sites were analyzed during three different pacing modes (biventricular (BiV), right ventricular (RV)-only, and left ventricular (LV)-only) pacing. Results: Stimulus to end of local electrogram duration (Stim-to-eEGM) depended significantly on the stimulation site (BiV, LV, or RV, p = 0.032). Single-chamber pacing unmasked LPs, not present during BiV pacing, in three patients. In another three patients, a concomitant increase in stimulus to end of surface QRS duration caused by single-site pacing compensated for the increase in Stim-to-eEGM duration, thereby prohibiting LP unmasking. Conclusion: The sequence of ventricular activation, as determined by the pacing site in patients with CRT devices, has a major influence on the detection of late potentials during substrate-guided ablation. Further study is warranted to define the optimal approaches, including the rhythm, for substrate mapping, but our findings suggest that BiV pacing may be most likely to obscure detection of late potentials as compared to single-site pacing.
AB - Purpose: Targets for substrate-based catheter ablation of scar-related ventricular tachycardia (VT) include sites with fractionated and late potentials (LPs). We hypothesized that in patients with cardiac resynchronization therapy (CRT), the pacing mode may influence the timing of abnormal electrograms (EGMs) relative to the surface QRS complex. Methods: We assessed bipolar EGM characteristics in left ventricular low bipolar voltage areas (< 1.5 mV) from 10 patients with coronary disease and a CRT device undergoing catheter ablation for VT. EGMs at 81 sites were analyzed during three different pacing modes (biventricular (BiV), right ventricular (RV)-only, and left ventricular (LV)-only) pacing. Results: Stimulus to end of local electrogram duration (Stim-to-eEGM) depended significantly on the stimulation site (BiV, LV, or RV, p = 0.032). Single-chamber pacing unmasked LPs, not present during BiV pacing, in three patients. In another three patients, a concomitant increase in stimulus to end of surface QRS duration caused by single-site pacing compensated for the increase in Stim-to-eEGM duration, thereby prohibiting LP unmasking. Conclusion: The sequence of ventricular activation, as determined by the pacing site in patients with CRT devices, has a major influence on the detection of late potentials during substrate-guided ablation. Further study is warranted to define the optimal approaches, including the rhythm, for substrate mapping, but our findings suggest that BiV pacing may be most likely to obscure detection of late potentials as compared to single-site pacing.
KW - Cardiac resynchronization therapy
KW - Catheter ablation
KW - Ischemic heart disease
KW - Substrate modification
KW - Ventricular tachycardia
UR - http://www.scopus.com/inward/record.url?scp=85064754992&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064754992&partnerID=8YFLogxK
U2 - 10.1007/s10840-019-00548-5
DO - 10.1007/s10840-019-00548-5
M3 - Article
C2 - 31020468
AN - SCOPUS:85064754992
SN - 1383-875X
VL - 55
SP - 55
EP - 62
JO - Journal of Interventional Cardiac Electrophysiology
JF - Journal of Interventional Cardiac Electrophysiology
IS - 1
ER -